2018 International Congress Archives - Page 42 of 177

1:45pm-3:15pm: Prevalence of focal task specific lower extremity dystonia symptoms in runners

R. Thompson, A. Hellman, D. Torres-Russotto (Lebanon, NH, USA)

Dystonia · Hall 3FG

1:45pm-3:15pm: Prevalence of REM sleep behavior disorder and sleep-disordered breathing in multiple system atrophy: A meta-analysis

SL. Wu, CS. Chuang (Changhua, Taiwan)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Hall 3FG

1:45pm-3:15pm: Prevalence of REM Sleep Behavior Disorder in Sun City, Arizona

D. Shprecher, A. Intorcia, M. Glass, J. Curry, J. Walker, B. Cutler, M. Callan, G. Serrano, N. Zhang, L. Sue, K. Davis, T. Beach (Sun City, AZ, USA)

Epidemiology · Hall 3FG

1:45pm-3:15pm: Prevalence of Single Nucleotide Polymorphisms (SNPs) rs362307 or rs362331 in Patients with Huntington’s Disease

S. Hung, D. Claassen, M. Edmondson, R. Reilmann, N. Svrzikapa, K. Longo, J. Goyal, M. Panzara (Cambridge, MA, USA)

Huntington's Disease · Hall 3FG

1:45pm-3:15pm: Prevelance in the World

Tur. Djakhangir (Tashkent, Uzbekistan)

Epidemiology · Hall 3FG

1:45pm-3:15pm: Probable MSA presenting initially with urinary retention

S. Simeoni, R. Sakakibara, J. Panicker (London, United Kingdom)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Hall 3FG

1:45pm-3:15pm: Prodromal features of Parkinson’s disease in women

K. Hughes, X. Gao, J. Baker, C. Stephen, I. Kim, L. Valeri, M. Schwarzschild, A. Ascherio (Boston, MA, USA)

Epidemiology · Hall 3FG

1:45pm-3:15pm: Progressive encephalomyelitis with rigidity and myoclonus (PERM): Phenomenology, investigations and management of two recent cases

T. Munteanu, Y. LLamas-Osorio, P. Cullinane, T. Lynch (Dublin, Ireland)

Other · Hall 3FG

1:45pm-3:15pm: Progressive Supranuclear Palsy and Eye of the Tiger Sign

O. Dogu, H. Genç, N. Öksüz (Mersin, Turkey)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Hall 3FG

1:45pm-3:15pm: PROMESA: A randomised, double-blind, placebo-controlled trial to evaluate the progression rate of MSA under EGCG supplementation as anti-aggregation-approach

J. Levin, S. Maass, M. Schuberth, A. Giese, W. Oertel, W. Poewe, C. Trenkwalder, G. Wenning, U. Mansmann, M. Suedmeyer, K. Eggert, B. Mollenhauer, A. Lipp, M. Loehle, J. Classen, A. Muenchau, J. Kassubeck, G. Ebersbach, D. Berg, S. Egert, C. Eberhardt, F. Paul, K. Boetzel, B. Ertl-Wagner, H. Huppertz, I. Ricard, G. Hoeglinger (Munich, Germany)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Hall 3FG